CC-90001

· Celgene Corporation

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CC-90001, covering 2014-10-15 to 2023-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis [Phase 2]